Patents
More topics under "C07D - Heterocyclic compounds" (1,537,440)
C07D 201 - Preparation, separation, purification, or stabilisation of unsubstituted lactams (2,192)
C07D 203 - Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom (1,097)
C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868)
C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
C07D 219 - Heterocyclic compounds containing acridine or hydrogenated acridine ring systems (2,120)
C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
C07D 225 - Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom (1,649)
C07D 227 - Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups (473)
C07D 229 - Heterocyclic compounds containing rings of less than five members having two nitrogen atoms as the only ring hetero atoms (515)
C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468)
C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
C07D 245 - Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms (898)
C07D 247 - Heterocyclic compounds containing rings having two nitrogen atoms as the only ring hetero atoms, according to more than one of groups (239)
C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
C07D 251 - Heterocyclic compounds containing 1,3,5-triazine rings (10,913)
C07D 253 - Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group (2,967)
C07D 255 - Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups (739)
C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
C07D 259 - Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms (488)
C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459)
C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
C07D 267 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms (2,022)
C07D 269 - Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms according to more than one of groups (111)
C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144)
C07D 273 - Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups (2,368)
C07D 275 - Heterocyclic compounds containing 1, 2-thiazole or hydrogenated 1,2-thiazole rings (4,972)
C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149)
C07D 281 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms (1,924)
C07D 283 - Heterocyclic compounds containing rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms, according to more than one of groups (102)
C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
C07D 291 - Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms (1,087)
C07D 293 - Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms (553)
C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
C07D 301 - Preparation of oxiranes (10,136)
C07D 303 - Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom (12,512)
C07D 305 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms (5,442)
C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
C07D 313 - Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom (3,580)
C07D 315 - Heterocyclic compounds containing rings having one oxygen atom as the only ring hetero atom according to more than one of groups (1,360)
C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
C07D 321 - Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups (2,079)
C07D 323 - Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms (1,581)
C07D 325 - Heterocyclic compounds containing rings having oxygen as the only ring hetero atom according to more than one of groups (168)
C07D 327 - Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms (2,428)
C07D 329 - Heterocyclic compounds containing rings having oxygen and selenium or oxygen and tellurium atoms as the only ring hetero atoms (47)
C07D 331 - Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom (456)
C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
C07D 335 - Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom (4,725)
C07D 337 - Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom (875)
C07D 339 - Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms (3,352)
C07D 341 - Heterocyclic compounds containing rings having three or more sulfur atoms as the only ring hetero atoms (281)
C07D 343 - Heterocyclic compounds containing rings having sulfur and selenium or sulfur and tellurium atoms as the only ring hetero atoms (52)
C07D 345 - Heterocyclic compounds containing rings having selenium or tellurium atoms as the only ring hetero atoms (419)
C07D 347 - Heterocyclic compounds containing rings having halogen atoms as ring hetero atoms (38)
C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
C07D 411 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms (2,465)
C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
C07D 415 - Heterocyclic compounds containing the thiamine skeleton (90)
C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
C07D 419 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms (1,431)
C07D 421 - Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms (480)
C07D 451 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof (5,273)
C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
C07D 455 - Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine (2,122)
C07D 457 - Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula: , e.g. lysergic acid (836)
C07D 459 - Heterocyclic compounds containing benz [g] indolo [2, 3-a] quinolizine ring systems, e.g. yohimbine; 16, 18-lactones thereof, e.g. reserpic acid lactone (97)
C07D 461 - Heterocyclic compounds containing indolo [3, 2, 1-d, e] pyrido [3, 2, 1-i, j] [1, 5]-naphthyridine ring systems, e.g. vincamine (286)
C07D 463 - Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (613)
C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
C07D 475 - Heterocyclic compounds containing pteridine ring systems (2,718)
C07D 477 - Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (2,484)
C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
C07D 489 - Heterocyclic compounds containing 4ah-8, 9 c- iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: (2,334)
C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
C07D 497 - Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms (1,069)
C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
C07D 499 - Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (3,448)
C07D 501 - Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (7,574)
C07D 503 - Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (648)
C07D 505 - Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (556)
C07D 507 - Heterocyclic compounds containing a condensed beta-lactam ring system, not provided for by groups , or; Such ring systems being further condensed (161)
C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
C07D 515 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (877)
C07D 517 - Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms (452)
C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)
Patents for C07D - Heterocyclic compounds (10,420)
04/2000
04/26/2000CN1251589A Substituted triazolo-pyridazine derivatives as ligands for GABA receptors
04/25/2000US6054592 Chemical intermediate for pesticide, fungicide
04/25/2000US6054464 Azabicyclic esters of carbamic acids useful in therapy
04/25/2000US6054434 8a-azalides as veterinary antimicrobal agents
04/21/2000CA2286646A1 Process and intermediates for preparing nicotinamide derivatives
04/20/2000WO2000023431A1 Method for the preparation of citalopram
04/20/2000WO2000021930A1 Esters of (+)-alpha-( 2,3- dimethoxyphenyl) -1-[2-(4- fluorophenyl) ethyl]-4- piperidinemethanol and their use as prodrugs of the 5ht2a receptor antagonist mdl 110,907
04/19/2000EP0994115A2 Process for preparation of pyrazolo-(4,3-d)pyrimidin-7-ones and intermediates thereof
04/19/2000EP0993452A1 Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives
04/19/2000EP0993442A1 Hydrazine derivatives
04/19/2000CN1251101A Salt of naphthyridine carobxylic acide derivative
04/18/2000US6051713 Substituted aryl or heteroarylamides having retinoid-like biological activity
04/18/2000US6051709 Process for the diastereoselective synthesis of nucleoside analogues
04/18/2000US6051581 Spiro-azabicyclic compounds useful in therapy
04/18/2000US6051566 Anti-reactive anti-asthmatic activity of non-steroidal anti-inflammatory drugs by inhalation
04/13/2000WO2000020397A1 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors
04/13/2000CA2346037A1 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors
04/12/2000EP0992510A1 N6 heterocyclic substituted adenosine derivatives
04/12/2000EP0992503A1 Process for producing isooxazolidinedione compound
04/12/2000EP0991654A1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same
04/12/2000EP0991653A1 Novel compounds
04/12/2000EP0991641A1 Omeprazole sodium salt
04/12/2000EP0991628A1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR P56?lck TYROSINE KINASES
04/12/2000EP0991625A2 Inhibitors of factor xa with a neutral p1 specificity group
04/12/2000EP0991620A1 Pyrrolidine carboxylic acid derivatives as endothelin antagonists
04/12/2000CN1250443A Saccharine-5-carbonyl-cyclohexane-1,3,5-trione derivatives,their preparation and their use as herbicides
04/12/2000CN1051315C Phosphonooxymethyl ethers of taxane derivatives
04/11/2000US6048873 Skin disorders
04/11/2000CA1340955C Stilbene derivatives
04/06/2000WO2000018734A1 Novel substituted indolinones with an inhibitory effect on various kinases and cyclin/cdk complexes
04/06/2000CA2342622A1 New substituted indolinones,their preparation and their use as medicaments
04/04/2000US6046304 Block oligomers containing 2,2,6,6-tetramethyl-4-piperidyl groups as stabilizers for organic materials
04/04/2000US6046223 Treatment of macular edema
04/04/2000CA2204739C Macrocyclic lactone compounds and their production process
03/2000
03/30/2000WO2000017167A1 Aminoalkyl-3,4-dihydroquinoline derivates as no-synthase inhibitors
03/30/2000WO2000017165A1 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors
03/30/2000WO2000017164A1 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors
03/30/2000DE19845830A1 Aminoalkyl-3,4-dihydrochinolin-Derivate und ihre Verwendung in Arzneimitteln Aminoalkyl-3,4-dihydroquinoline derivatives and their use in medicaments
03/30/2000DE19844003A1 New 3-aminomethylidene-2-indolinone derivatives useful as kinase inhibitors and antiproliferative agents e.g. for treating viral infections, tumors, inflammation or autoimmune disease
03/30/2000CA2340990A1 Aminoalkyl-3,4-dihydroquinoline derivates as no-synthase inhibitors
03/29/2000EP0988300A1 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives for the inhibition of farnesyl protein transferase
03/29/2000CN1050839C Sulfonylamino pyrimidines compounds, medicinal composition containing same, its preparation process and use
03/29/2000CN1050836C Macrocyclic bifunctional chelants, complexes thereof and their antibody conjugates preparation process
03/29/2000CN1050833C Process for the preparation of acid chloride
03/22/2000EP0987269A1 Salts of optically active sulfoxide derivative
03/22/2000CN1050603C Prepn. of intermediate product used in process for diastereoselective synthesis of nucleosides
03/16/2000WO2000014066A1 4,4-biarylpiperidine derivatives with opioid receptor activity
03/15/2000EP0984965A1 8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ach receptors
03/15/2000EP0984957A1 NOVEL FORM OF $i(S)OMEPRAZOLE
03/15/2000EP0850232B1 Benzothiazolone derivatives
03/15/2000CN1247539A Process for preparing eprosartan
03/15/2000CN1247532A Substituted 4-benzoyl-pyrazoles
03/09/2000WO2000012484A1 Tan-1057 derivatives
03/09/2000WO2000012478A1 Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp)
03/09/2000DE19838998A1 Neue Naturstoffderivate New natural product derivatives
03/08/2000EP0984013A2 Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1, 3-oxathiolane
03/08/2000EP0983264A1 Method of manufacturing sertindole
03/08/2000EP0800527B1 Novel processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof
03/08/2000EP0591355B1 Porphycene compounds for photodynamic therapy
03/08/2000CN1246858A Substituted pyrimidine compounds and their use
03/08/2000CN1050126C Tri-substituted imidazoles compound, process for preparing it and use and pharmaceutical compositions containing them
03/07/2000US6034083 Agricultural insecticide
03/02/2000WO2000011001A1 Muscarinic agonists and antagonists
03/02/2000CA2340946A1 Muscarinic agonists and antagonists
03/01/2000EP0982307A2 9 -Amino- and 9-nitro-camptothecin derivatives, process for their preparation and use as antitumor agents
03/01/2000EP0981527A1 Salt of naphthyridine carboxylic acid derivative
03/01/2000CN1246124A 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
03/01/2000CN1246113A Process for crystallization of reverse transcriptase inhibitor using anti-solvent
03/01/2000CN1246111A Novel compound with analgesic effect
02/2000
02/29/2000CA2017535C Antispasmodic agents
02/24/2000WO2000009485A1 Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors
02/23/2000EP0980354A2 Vitamin d 3? analogs with bis c-20 side chains
02/23/2000CN1049657C Process for preparing substituted benzopyran derivatives
02/22/2000US6028035 Substituted 4-benzoylpyrazoles
02/22/2000CA2081356C Derivatives and analogues of 2-deoxy-2,3-didehydro-n- acetyl neuraminic acid and their use as antiviral agents
02/17/2000WO2000007987A1 Crystalline forms of osanetant
02/17/2000WO2000007965A1 Method for reacting an organic compound with a hydroperoxide
02/17/2000DE19835907A1 Verfahren zur Umsetzung einer organischen Verbindung mit einem Hydroperoxid A process for reacting an organic compound with a hydroperoxide
02/17/2000CA2339710A1 Process for the reaction of an organic compound with a hydroperoxide
02/17/2000CA2339007A1 Crystalline forms of osanetant
02/16/2000EP0979827A1 Peptides having tachykinin antagonist activity, a process for preparation thereof and pharmaceutical compositions comprising the same
02/16/2000EP0979034A1 Composition for controlling harmful bio-organisms and method for controlling harmful bio-organisms using the same
02/16/2000CN1244528A Di- Or triaza-spiral [4,5] decane derivative
02/09/2000CN1244122A Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
02/09/2000CN1049215C Pharmaceutical compounds
02/08/2000US6022967 Heterocyclic compounds
02/08/2000CA2150016C Pyrrolopyrimidines as crf antagonists
02/08/2000CA2014467C 3-substituted-2-oxindole derivatives
02/03/2000WO1999064417A3 Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
02/03/2000WO1999061444A3 Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation
02/03/2000CA2337247A1 Isquinolines as urokinase inhibitors
02/02/2000EP0975637A2 Amidino-camptothecin derivatives
02/02/2000EP0975609A1 Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent
02/02/2000EP0975599A1 Subtituted isoquinolines as ultra short acting neuromuscular blockers
02/02/2000CN1048982C Method for semi-synthesis of taxalkane derivative with metal alkane oxide and beta-lactum
01/2000
01/27/2000WO2000004020A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation
01/27/2000WO2000003992A1 Quinoline derivatives
01/27/2000CA2337377A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation
01/26/2000EP0973534A1 Pharmaceutical compositions having appetite suppressant activity
01/26/2000EP0670839B1 Process for the preparation of 9-amino camptothecin
1 ... 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 ... 105